Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been in the headlines lately, owing in large part to former Grey's Anatomy actor Eric Dane opening up about his battle with ...
A longitudinal study of 100 ALS patients shows that combined serum levels of 4-HNE, LBP, and NfL discriminate rapid disease progression and poor survival with high accuracy.
ALS (Amyotrophic Lateral Sclerosis) is a fatal neurodegenerative disease that gradually affects a person's ability to move, speak, and breathe. It advances differently in every patient. Now, ...
Months to several years before amyotrophic lateral sclerosis (ALS) symptoms arise, levels of certain blood proteins may shift dramatically. Researchers analyzed data from the long-running ...
A German population-based study showed that 12% of patients with amyotrophic lateral sclerosis (ALS) survived at least 10 years from the onset of symptoms, with a median survival of 2.5 years, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results